
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective
Ranran Wang, Tianyi Yuan, Jianmei Wang, et al.
Pharmacological Research (2022) Vol. 180, pp. 106238-106238
Closed Access | Times Cited: 55
Ranran Wang, Tianyi Yuan, Jianmei Wang, et al.
Pharmacological Research (2022) Vol. 180, pp. 106238-106238
Closed Access | Times Cited: 55
Showing 1-25 of 55 citing articles:
Role of macrophages in pulmonary arterial hypertension
Mengqi Zhang, Chenchen Wang, Xiaobin Pang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Mengqi Zhang, Chenchen Wang, Xiaobin Pang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Therapeutic potential of natural flavonoids in pulmonary arterial hypertension: A review
Jinjing Zhang, Mao-mao, Minmin Shao, et al.
Phytomedicine (2024) Vol. 128, pp. 155535-155535
Closed Access | Times Cited: 10
Jinjing Zhang, Mao-mao, Minmin Shao, et al.
Phytomedicine (2024) Vol. 128, pp. 155535-155535
Closed Access | Times Cited: 10
The role of immune cells and inflammation in pulmonary hypertension: mechanisms and implications
Hui Zhao, Jialin Song, Xiujun Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Hui Zhao, Jialin Song, Xiujun Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Human BioMolecular Atlas Program (HuBMAP): 3D Human Reference Atlas Construction and Usage
Katy Börner, Philip D. Blood, Jonathan C. Silverstein, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Katy Börner, Philip D. Blood, Jonathan C. Silverstein, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Inhibition of Glutaminase 1 Reduces M1 Macrophage Polarization to Protect Against Monocrotaline-Induced Pulmonary Arterial Hypertension
Xing Chen, Lixiang Li, Yan Deng, et al.
Immunology Letters (2025) Vol. 272, pp. 106974-106974
Open Access
Xing Chen, Lixiang Li, Yan Deng, et al.
Immunology Letters (2025) Vol. 272, pp. 106974-106974
Open Access
Long-term trends in the burden of pulmonary arterial hypertension in China and worldwide: new insights based on GBD 2021
Zhehao Xu, Jia Ding, Ruixin Liang, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Zhehao Xu, Jia Ding, Ruixin Liang, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Targeted FTO Knockout in Endothelial Cells Boosts Adhesion and Lowers Inflammatory Infiltration to Alleviate Pulmonary Arterial Hypertension
Ziwen Zhao, Mengmeng Sang, Qi Li, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151339-151339
Open Access
Ziwen Zhao, Mengmeng Sang, Qi Li, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151339-151339
Open Access
Dysfunction in mitochondrial electron transport chain drives the pathogenesis of pulmonary arterial hypertension: insights from a multi-omics investigation
Xin Zhang, Jieling Li, Minyi Fu, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Xin Zhang, Jieling Li, Minyi Fu, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Cyclic nucleotide phosphodiesterases as drug targets
Michy P. Kelly, Viacheslav O. Nikolaev, Leila Gobejishvili, et al.
Pharmacological Reviews (2025), pp. 100042-100042
Open Access
Michy P. Kelly, Viacheslav O. Nikolaev, Leila Gobejishvili, et al.
Pharmacological Reviews (2025), pp. 100042-100042
Open Access
Triangular Causality Among Pulmonary Hypertension, Sleep Disorders, and Brain Structure at the Genetic Level: A Mendelian Randomization Study Focused on the Lung-Brain Axis
Chenwei Zhang, Xuesen Su, Yukai Zhang, et al.
Nature and Science of Sleep (2025) Vol. Volume 17, pp. 343-356
Open Access
Chenwei Zhang, Xuesen Su, Yukai Zhang, et al.
Nature and Science of Sleep (2025) Vol. Volume 17, pp. 343-356
Open Access
New LFA-1 inhibitor Orientin reduces angiotensin II-induced vascular remodeling
Yitong Wang, Ying Zhang, Xiangbo An, et al.
European Journal of Pharmacology (2025) Vol. 995, pp. 177426-177426
Open Access
Yitong Wang, Ying Zhang, Xiangbo An, et al.
European Journal of Pharmacology (2025) Vol. 995, pp. 177426-177426
Open Access
Single-Cell Sequencing Reveals Cell Heterogeneity and Key Regulatory Networks Associated with Pulmonary Arterial Hypertension
Guangwei Huang, Dai Hailong
(2025)
Closed Access
Guangwei Huang, Dai Hailong
(2025)
Closed Access
Promising dawn in the management of pulmonary hypertension: The mystery veil of gut microbiota
Yicheng Yang, Hanwen Zhang, Yaoyao Wang, et al.
iMeta (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 4
Yicheng Yang, Hanwen Zhang, Yaoyao Wang, et al.
iMeta (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 4
Role of the Systemic Inflammatory Response Index in Predicting Disease Severity and Prognosis in Idiopathic Pulmonary Arterial Hypertension
Luyang Gao, Sicheng Zhang, Zhihui Zhao, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 447-460
Open Access | Times Cited: 4
Luyang Gao, Sicheng Zhang, Zhihui Zhao, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 447-460
Open Access | Times Cited: 4
Causal association of depression, anxiety, cognitive performance, the brain cortical structure with pulmonary arterial hypertension: A Mendelian randomization study
Zeying Zhang, Shelby Kutty, Wei Peng, et al.
Journal of Affective Disorders (2024) Vol. 356, pp. 356-362
Closed Access | Times Cited: 3
Zeying Zhang, Shelby Kutty, Wei Peng, et al.
Journal of Affective Disorders (2024) Vol. 356, pp. 356-362
Closed Access | Times Cited: 3
Natural Targeting Potent ROS‐Eliminating Tungsten‐Based Polyoxometalate Nanodots for Efficient Treatment of Pulmonary Hypertension
Hong Liu, Shuya Wang, Qiaohui Chen, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 22
Closed Access | Times Cited: 8
Hong Liu, Shuya Wang, Qiaohui Chen, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 22
Closed Access | Times Cited: 8
Lactylation Modification in Cardiometabolic Disorders: Function and Mechanism
Xu Li, Pingdong Cai, Xinyuan Tang, et al.
Metabolites (2024) Vol. 14, Iss. 4, pp. 217-217
Open Access | Times Cited: 2
Xu Li, Pingdong Cai, Xinyuan Tang, et al.
Metabolites (2024) Vol. 14, Iss. 4, pp. 217-217
Open Access | Times Cited: 2
Ormeloxifene, a selective estrogen receptor modulator, protects against pulmonary hypertension
Adam Olaitan Abdulkareem, Priya Tiwari, Zahid Rasool Lone, et al.
European Journal of Pharmacology (2023) Vol. 943, pp. 175558-175558
Closed Access | Times Cited: 6
Adam Olaitan Abdulkareem, Priya Tiwari, Zahid Rasool Lone, et al.
European Journal of Pharmacology (2023) Vol. 943, pp. 175558-175558
Closed Access | Times Cited: 6
The Role of Inflammation in The Cellular and Molecular Mechanisms of Cardiopulmonary Complications of Sickle Cell Disease
Oluwabukola T. Gbotosho, Jahnavi Gollamudi, Hyacinth I. Hyacinth
Biomolecules (2023) Vol. 13, Iss. 2, pp. 381-381
Open Access | Times Cited: 6
Oluwabukola T. Gbotosho, Jahnavi Gollamudi, Hyacinth I. Hyacinth
Biomolecules (2023) Vol. 13, Iss. 2, pp. 381-381
Open Access | Times Cited: 6
Transcription factors and potential therapeutic targets for pulmonary hypertension
Yang Liu, Naifu Wan, Fanpeng Gong, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 6
Yang Liu, Naifu Wan, Fanpeng Gong, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 6
Myeloid-derived suppressor cells and pulmonary hypertension
Hui Zhang, Qiwei Li, Yuanyuan Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Hui Zhang, Qiwei Li, Yuanyuan Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Expression of Inflammatory Genes in Murine Lungs in a Model of Experimental Pulmonary Hypertension: Effects of an Antibody-Based Targeted Delivery of Interleukin-9
Judith Heiß, Katja Grün, Isabell Singerer, et al.
Advances in respiratory medicine (2024) Vol. 92, Iss. 1, pp. 27-35
Open Access | Times Cited: 1
Judith Heiß, Katja Grün, Isabell Singerer, et al.
Advances in respiratory medicine (2024) Vol. 92, Iss. 1, pp. 27-35
Open Access | Times Cited: 1
Periodontitis exacerbates pulmonary hypertension by promoting IFNγ+ T cell infiltration in mice
Xiao-Qian Meng, Lin‐Juan Du, Shuo Xu, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Xiao-Qian Meng, Lin‐Juan Du, Shuo Xu, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Integrated bioinformatics analysis and experimental animal models identify a robust biomarker and its correlation with the immune microenvironment in pulmonary arterial hypertension
Mukamengjiang Juaiti, Yilu Feng, Yiyang Tang, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e29587-e29587
Open Access | Times Cited: 1
Mukamengjiang Juaiti, Yilu Feng, Yiyang Tang, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e29587-e29587
Open Access | Times Cited: 1
No genetic causal association between iron status and pulmonary artery hypertension: Insights from a two‐sample Mendelian randomization
Pengcheng Liu, Meng‐Na Lv, Yanyan Rong, et al.
Pulmonary Circulation (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 1
Pengcheng Liu, Meng‐Na Lv, Yanyan Rong, et al.
Pulmonary Circulation (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 1